CDK7 and neoplasm: Deletion of CDK7 dramatically impaired the tumor growth of FaDu and HCA-LSC1 cell lines subcutaneously injected in immunodeficient mice (Fig. 5a), reaching final tumor volume reductions of 60 and 75% respectively (Fig. 5b).